Both budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol provide the guideline-recommended combination of inhaled corticosteroid-long acting muscarinic antagonist (LAMA ...

The pharmacotherapy of schizophrenia is currently dominated by atypical antipsychotics that primarily target dopaminergic signalling, the dysregulation of which has long been considered to have a ...

(“Neurocrine”) regarding the clinical development of its partnered muscarinic agonist portfolio. These updates were presented by Neurocrine at the 43 rd Annual J.P. Morgan Healthcare Conferen ...

Ltd. (“Nxera” or “the Company”; TSE 4565) is pleased to report on progress being made by Neurocrine Biosciences, Inc. (“Neurocrine”) regarding the clinical development of its partnered muscarinic ...

Ltd. ("Nxera” or "the Company”; TSE 4565) is pleased to report on progress being made by Neurocrine Biosciences, Inc. ("Neurocrine”) regarding the clinical development of its partnered muscarinic ...